Month: November 2025

Alpha blockers can significantly reduce urinary symptoms during the initial weeks of treatment by relaxing the muscle fibres in the prostate and bladder neck; however, they do not reduce the physical size of the prostate itself. These medications work by relaxing smooth muscle fibres (the involuntary muscles that control various bodily functions) in the prostate and bladder neck, reducing the physical blockage that causes urinary symptoms. While classified as first-line medications for benign prostatic hyperplasia (BPH), alpha blockers address symptoms rather than the underlying prostate enlargement. This distinction becomes critical as the prostate continues to grow over time.

A healthcare provider typically recommends alpha blocker therapy following a thorough evaluation of symptom severity, prostate size, and individual health factors.

How Alpha Blockers Work in BPH

The prostate and bladder neck contain alpha-1 adrenergic receptors (specialised protein structures on cell surfaces) that, when activated, cause smooth muscle contraction. In BPH, this muscle tension compounds the mechanical obstruction from prostate tissue growth.

Alpha blockers selectively inhibit these receptors. This causes muscle relaxation throughout the lower urinary tract. This relaxation widens the prostatic urethra (the tube that carries urine through the prostate) and reduces bladder outlet resistance. Urine flows more freely without addressing the actual prostate tissue volume.

The effect occurs relatively quickly compared to other BPH medications. Most men notice improvement in urinary symptoms within days to weeks of starting treatment. Maximum benefit typically develops over the first month.

Commonly Prescribed Alpha Blockers

Tamsulosin is one of the frequently prescribed alpha blockers for BPH. Its selectivity for prostate tissue receptors reduces cardiovascular side effects compared to older, non-selective agents. Standard dosing is once daily, typically taken after the same meal each day.

Alfuzosin offers similar prostate selectivity with once-daily extended-release dosing. The typical formulation is taken after the evening meal to optimise absorption and minimise daytime side effects.

Silodosin provides high prostate selectivity. This may reduce blood pressure effects but increases the likelihood of retrograde ejaculation (semen flowing backwards into the bladder instead of exiting the body). The typical dose is once daily with food.

Terazosin and doxazosin are older, non-selective alpha blockers that require a gradual dose increase to minimise blood pressure drops. While effective for BPH, healthcare providers now choose them less commonly as first-line options due to their cardiovascular effects.

Benefits of Alpha Blocker Therapy

Alpha blockers improve urinary symptoms without shrinking the prostate. Men typically experience:

• Better urinary flow
• Reduced frequency (fewer trips to the bathroom)
• Less urgency (a sudden, strong need to urinate)
• Fewer episodes of nighttime urination

The medications work regardless of prostate size. Men with smaller prostates often experience proportionally greater symptom relief since their obstruction is more dynamic (muscle-related) than mechanical (tissue-related).

Symptom improvement remains stable during continued therapy. The underlying prostate may continue to enlarge over time. This progressive growth can eventually overcome the medication’s benefits, requiring treatment adjustment.

💡 Did You Know?
Alpha blockers relax smooth muscle throughout the body, not just in the prostate. This explains why some men experience nasal congestion as a side effect—the same muscle relaxation occurs in nasal blood vessels.

Limitations Men Should Understand

No Effect on Prostate Size

Alpha blockers do not shrink prostate tissue or slow prostate growth. The prostate continues its natural enlargement trajectory. This may eventually require additional or alternative treatment. Men with significantly enlarged prostates may find alpha blocker benefits insufficient from the outset.

Symptom Management, Not Disease Modification

These medications address muscle tone rather than tissue volume. Stopping treatment typically results in symptom return. Alpha blockers require indefinite use to maintain their effects, unlike some surgical interventions that can provide lasting improvement.

Variable Individual Response

Response to alpha blocker therapy varies among patients based on individual health factors. Some experience substantial symptom improvement while others notice minimal benefit. Healthcare providers find predicting individual response before starting treatment difficult. Men with smaller prostates and predominant irritative symptoms (such as urgency and frequency) often respond favourably. A doctor will monitor the response over the first few weeks to determine whether the medication is effective.

Declining Effectiveness Over Time

As prostate enlargement progresses, the mechanical component of obstruction (physical tissue blocking the urethra) increases relative to the dynamic component (muscle tension). Alpha blockers become progressively less effective at compensating for this growing tissue mass. Healthcare providers sometimes call this phenomenon “treatment escape.”

Common Side Effects and Management

Orthostatic Hypotension

Blood pressure drops upon standing occur most frequently with non-selective alpha blockers, but can happen with any agent in this class. The risk increases in men taking blood pressure medications, those with dehydration, or during hot weather.

Rising slowly from sitting or lying positions helps prevent dizziness and falls. Taking the medication at bedtime rather than in the morning reduces daytime symptoms for some men.

Retrograde Ejaculation

Relaxation of the bladder neck muscles can prevent normal ejaculatory function. This directs semen backwards into the bladder rather than forward through the urethra. This side effect occurs frequently with silodosin and tamsulosin.

Retrograde ejaculation doesn’t affect orgasm sensation or cause harm. It does affect fertility. The condition reverses upon stopping medication.

Nasal Congestion

Smooth muscle relaxation in nasal blood vessels causes swelling and congestion. This effect typically improves over weeks of continued use. Nasal saline rinses provide symptomatic relief without interfering with the medication.

Intraoperative Floppy Iris Syndrome

Men taking alpha blockers who undergo cataract surgery (a procedure to remove clouding from the eye’s lens) face an increased risk of iris complications during the procedure. Inform an ophthalmologist (eye surgeon) about alpha blocker use—even if stopped months earlier. This allows surgical technique modifications that reduce the risk of complications.

⚠️ Important Note
Always inform eye surgeons about current or previous alpha blocker use before cataract procedures. The iris changes can persist even after stopping medication.

When Alpha Blockers May Not Be Enough

Several clinical situations suggest that alpha blocker monotherapy may prove insufficient:

• Large Prostate Volume: Larger prostates often require combination therapy or surgical consideration, as the mechanical obstruction component (tissue blocking the flow) predominates over dynamic factors (muscle tension).
• Urinary Retention Episodes: Men who have experienced acute urinary retention (complete inability to pass urine) face a higher risk of recurrence despite alpha blocker therapy. These episodes often indicate obstruction requiring more definitive treatment.
• Elevated Post-Void Residual: Significant urine remaining in the bladder after voiding suggests bladder decompensation (weakening of bladder function) that may not respond adequately to medication alone.
• Recurrent Urinary Tract Infections: Chronic incomplete bladder emptying creates an environment for bacterial growth. Repeated infections despite alpha-blocker use indicate inadequate relief of obstruction.
• Bladder Stones or Bleeding: These complications of longstanding obstruction typically require surgical intervention rather than continued medical management.

Combination Therapy Approaches

Alpha Blockers Plus 5-Alpha Reductase Inhibitors

Adding finasteride or dutasteride to alpha-blocker therapy addresses both dynamic (muscle-related) and mechanical (tissue-related) components of obstruction. The 5-alpha reductase inhibitor (medications that block the hormone that causes prostate growth) gradually shrinks prostate tissue over months. The alpha blocker provides symptom relief.

This combination may be considered for men with larger prostates. The trade-off includes additional side effects and medication costs.

Alpha Blockers Plus Anticholinergics

For men with predominant storage symptoms—urgency, frequency, and urge incontinence (leaking urine due to a sudden urge)—adding an anticholinergic medication (drugs that calm overactive bladder muscles) targets bladder muscle overactivity. This combination requires careful monitoring of post-void residual volumes (the amount of urine left in the bladder after urinating) to avoid worsening retention.

Alpha Blockers Plus PDE5 Inhibitors

Tadalafil, typically used for erectile dysfunction, has demonstrated benefits for BPH symptoms through smooth muscle relaxation mechanisms. Daily low-dose tadalafil, combined with an alpha-blocker, may benefit men with both conditions. Blood pressure monitoring remains essential.

Making the Decision to Start Treatment

Alpha blocker therapy suits men with bothersome urinary symptoms willing to commit to ongoing medication. The relatively rapid onset of action makes these medications helpful in assessing symptoms. If significant improvement doesn’t occur within four to six weeks, alternative approaches should be considered.

Men should discuss their priorities openly with their urologist (a doctor who specialises in the urinary system and male reproductive health). Those who prefer avoiding long-term medication, have larger prostates, or have already experienced complications may benefit from earlier consideration of procedural or surgical options. A doctor will establish specific treatment goals tailored to individual risk factors, symptom severity, prostate size, overall health, and personal preferences.

✅ Quick Tip
Keep a bladder diary for one week before an appointment. Record voiding times, volumes, and symptoms. This information helps a urologist assess response to treatment and guide therapy adjustments.

When to Seek Professional Help

• Complete inability to urinate despite medication
• Blood in urine or semen
• Fever with urinary symptoms suggesting infection
• Significant worsening of symptoms despite compliance with medication
• Recurrent urinary tract infections
• Severe dizziness or falls related to medication side effects
• Planning for cataract surgery

Commonly Asked Questions

How long should I try alpha blockers before considering other treatments?

Most urologists recommend a four to six-week trial to assess response. If symptoms remain significantly bothersome after this period at appropriate dosing, discuss additional or alternative treatments with a healthcare provider.

Can I stop taking alpha blockers once symptoms improve?

Symptoms typically return within days to weeks of stopping medication. Alpha blockers don’t address underlying prostate enlargement. Some men attempt “drug holidays”, but usually require resuming treatment. Permanent discontinuation generally follows surgical intervention that resolves the obstruction.

Do alpha blockers interact with erectile dysfunction medications?

Both drug classes can lower blood pressure, creating additive effects. While many men safely use both, coordination between prescribing physicians and careful timing of doses reduces hypotension (low blood pressure). Starting at lower doses of each medication allows dose adjustment.

Why did my doctor prescribe a specific alpha blocker over others?

Healthcare providers typically consider side effect profiles matched to individual patient factors. Men concerned about ejaculatory function may receive alfuzosin rather than tamsulosin. Those with low blood pressure might avoid terazosin or doxazosin. Previous cataract surgery or planned eye procedures also influence selection.

Should I take alpha blockers before or after meals?

Food requirements vary by specific medication. Tamsulosin absorption improves when taken after the same meal daily. Alfuzosin extended-release requires food for proper absorption. Silodosin should be taken with food to reduce gastrointestinal side effects. A pharmacist can clarify requirements for a specific prescription.

Next Steps

Alpha blockers provide symptom relief without addressing prostate growth. Treatment effectiveness declines as prostate enlargement progresses. Early comprehensive evaluation determines whether combination therapy or surgical options better serve long-term management goals.

If you’re experiencing a weak urinary stream, frequent urination, or nighttime bathroom trips, consult with a urologist for evaluation and treatment options tailored to your prostate size and symptom severity.

Which surgical approach offers better outcomes for prostate cancer: robotic-assisted or traditional open surgery? Radical prostatectomy, the surgical removal of the prostate gland, remains one of the treatment options for localised prostate cancer. The procedure can be performed through two distinct approaches: robotic-assisted laparoscopic surgery or traditional open surgery. Both methods aim to achieve the same oncological goal: complete removal of cancerous tissue while preserving urinary continence and erectile function. The choice between approaches depends on multiple factors. These include:

• Tumour characteristics
• Patient anatomy
• Surgeon experience
• Individual treatment priorities

The clinical evidence presents a nuanced picture. In this picture, a surgeon’s expertise frequently matters more than the specific approach chosen.

How Each Surgical Approach Works

Open Radical Prostatectomy

Open surgery involves a single incision, typically 8-10 centimetres. Urologists make this incision either in the lower abdomen (retropubic approach) or between the scrotum and anus (perineal approach). Healthcare providers more commonly use the retropubic approach. It allows simultaneous removal of pelvic lymph nodes for staging purposes (to determine if cancer has spread).

The surgeon works directly within the surgical field, with their hands inside the body cavity. This provides tactile feedback, the ability to feel tissue texture and tension. Some urologists consider this valuable for identifying nerve bundles and assessing tissue planes. The procedure typically requires 2-4 hours of operative time.

Robotic-Assisted Radical Prostatectomy

Robotic surgery uses 5-6 small incisions (8-12 millimetres each). Urologists insert a camera and robotic instruments through these incisions. The surgeon operates from a console several metres away. The console controls instruments that translate hand movements into precise micro-movements inside the patient’s body.

The robotic system provides three-dimensional high-definition magnification (substantial magnification), tremor filtration, and instruments with a greater range of motion than the human wrist. The pneumoperitoneum (inflating the abdomen with gas to create working space) reduces bleeding. It does this by compressing small blood vessels.

Surgical and Perioperative Outcomes

Blood Loss and Transfusion

Robotic prostatectomy demonstrates reduced blood loss during surgery compared to open surgery. The pneumoperitoneum creates a tamponade effect, compressing the bleeding site and helping stop bleeding. Magnified visualisation allows precise vessel control. Most robotic procedures involve blood loss of less than 200 millilitres. Open surgery typically results in 500-1000 millilitres.

Transfusion requirements reflect this difference. Blood transfusion is uncommon in robotic surgery. Open procedures carry a higher likelihood of requiring transfusion, particularly in cases with larger prostates or previous pelvic surgery.

Hospital Stay and Recovery Timeline

Robotic surgery typically requires 1-2 nights in the hospital. Many centres now offer same-day discharge protocols for selected patients. Open surgery generally requires 2-4 nights of hospitalisation.

The smaller incisions in robotic surgery result in less postoperative pain and reduced pain medication requirements. Most robotic patients transition from intravenous to oral pain medication within 24 hours. They return to light activities within 1-2 weeks. Open surgery patients typically require longer pain management. They need 4-6 weeks before resuming similar activity levels.

Catheter duration is similar between approaches, usually 7-14 days. This relates to the internal urethral anastomosis (the reconnection of the urethra after the prostate is removed) rather than external incisions.

Complication Rates

Overall complication rates between the two approaches are comparable when performed by urologists. The types of complications differ slightly:

• Robotic surgery carries small risks of port-site hernia, a hernia developing at one of the small incision sites, subcutaneous emphysema (air trapped under the skin), and complications related to steep head-down positioning required during the procedure
• Open surgery has higher rates of wound-related complications, including infection and hernia at the incision site

Serious complications occur rarely with both approaches. These include:

• Ureteral injury, or damage to the tubes connecting the kidneys to the bladder
• Rectal injury
• Deep vein thrombosis or blood clots in leg veins

They depend more on case complexity and surgeon experience than on the chosen technique.

Oncological Outcomes: Cancer Control

The primary purpose of radical prostatectomy is cancer cure. Healthcare professionals measure oncological outcomes through favourable surgical margin rates (cancer cells at the edge of removed tissue, which may indicate incomplete removal) and biochemical recurrence (rising PSA levels after surgery, suggesting cancer may have returned).

Positive Surgical Margins

Current evidence shows equivalent favourable margin rates between robotic and open approaches when controlled for tumour stage and grade. Margins depend on cancer extent, prostate anatomy, and surgical decision-making about nerve preservation rather than the technical approach.

For organ-confined disease (cancer that hasn’t spread beyond the prostate), favourable margin rates are low regardless of approach. For cancers extending beyond the prostate capsule, rates increase. The decision to perform a wider excision rather than a nerve-sparing approach involves a trade-off between cancer control and functional preservation. This trade-off exists independent of surgical technique.

Long-term Cancer Control

Studies with 10-year follow-up demonstrate equivalent biochemical recurrence-free survival between approaches. The cancer’s biological characteristics predict recurrence more reliably than surgical technique. These characteristics include:

• Gleason grade, a scoring system that describes how aggressive the cancer cells look
• PSA level, a protein produced by the prostate that can indicate cancer activity
• Tumour volume

Neither approach offers different cancer cure rates. The choice between them should not be made primarily on oncological grounds.

Functional Outcomes: Continence and Potency

The two significant quality-of-life concerns following prostatectomy are urinary incontinence (inability to control urination) and erectile dysfunction (difficulty achieving or maintaining erections). Both result from the unavoidable proximity of the prostate to the urinary sphincter (the muscle that controls urine flow) and neurovascular bundles, where nerve and blood vessel bundles that control erection.

Urinary Continence Recovery

Healthcare professionals typically define continence as using no pads or one security pad daily. Recovery follows a predictable pattern with both approaches:

• Immediately after catheter removal, Most men experience some leakage
• 3 months: Many men achieve social continence (minimal leakage with activity)
• 6-12 months: Most men reach final continence status

Studies comparing robotic and open approaches show conflicting results. Some demonstrate faster early continence recovery with robotic surgery. Others show equivalent outcomes. By 12 months, continence rates are similar between approaches. Your doctor will monitor your recovery progress. They can recommend pelvic floor exercises or other interventions to help support continence recovery.

Pre-surgical factors predicting continence outcomes include:

• Younger age
• Lower body mass index
• Absence of lower urinary tract symptoms, such as a weak stream or frequent urinatio,n before surgery

Surgical factors include preservation of urethral length and bladder neck.

Erectile Function Recovery

Erectile function recovery depends on nerve preservation, patient age, and pre-operative function. Men with strong erections before surgery, under age 60, who receive bilateral nerve-sparing surgery, where nerves on both sides are preserved, have higher recovery rates.

The magnification available in robotic surgery, in theory, enables nerve identification. However, comparative studies have not shown differences in erectile function outcomes between the two approaches. Your doctor can provide personalised advice. This will be based on your age, pre-surgery function, and the extent of nerve preservation possible given your cancer characteristics.

Erectile recovery is gradual. It often takes 18-24 months to reach final status. Most men require phosphodiesterase inhibitors (medications like sildenafil that help improve blood flow for erections) during recovery, regardless of surgical approach.

💡 Did You Know?
The neurovascular bundles responsible for erection run along the posterolateral surface of the prostate. They sit within millimetres of the prostatic capsule. Even with meticulous nerve-sparing technique, temporary dysfunction occurs. This happens due to nerve stretching and inflammation during dissection. This explains why recovery takes months rather than weeks.

The Role of Surgeon Experience

A consistent finding across surgical literature is that surgeon volume and experience correlate strongly with outcomes. High-volume urologists, those who perform many prostatectomy procedures, achieve outcomes regardless of whether they use robotic or open techniques.

Experience manifests in multiple ways:

• Patient selection: Matching appropriate cases to appropriate approaches
• Intraoperative decision-making: Knowing when to preserve versus remove tissue
• Complication management: Recognising and addressing problems promptly
• Case efficiency: Reduced operative time decreases anaesthesia exposure

When choosing a surgeon, case volume and outcomes data matter.

Cost and Accessibility Considerations

Direct Costs

Robotic surgery involves higher direct costs. These stem from equipment acquisition (the surgical system costs several million pounds), annual maintenance, and single-use instruments required for each case. Shorter hospital stays and reduced blood product usage partially offset these costs.

In Singapore, the out-of-pocket difference between approaches varies by institution and subsidy eligibility. Some centres absorb the additional robotic costs. Others pass them to patients.

Surgeon Availability

Robotic surgery requires specialised training and a high volume of cases to maintain proficiency. Not all urologists perform robotic surgery. Not all hospitals have robotic systems. Healthcare providers can perform open surgery at any hospital with appropriate facilities.

For patients in regions without robotic access, urologists can still achieve outcomes through open surgery.

Making Your Decision

Several factors should guide the choice between approaches:

Favouring Robotic Surgery

• Body habitus makes open surgery technically challenging, such as obesity, and a deep and narrow pelvis
• Preference for smaller incisions and faster return to physical activity
• Availability of a robotic surgeon
• No contraindications to steep head-down positioning

Favouring Open Surgery

• Huge prostate where robotic advantages diminish
• Prior extensive abdominal surgery with adhesions (scar tissue)
• Surgeon’s primary expertise is open technique
• Medical conditions precluding prolonged pneumoperitoneum

Either Approach Reasonable

Many cases of localised prostate cancer fall into this category. Surgeon experience and patient preference appropriately guide the decision.

When to Seek Professional Help

• Elevated PSA level on a screening blood test
• Abnormal findings on digital rectal examination
• Urinary symptoms such as difficulty starting urination, a weak stream, or frequent nighttime urination
• Family history of prostate cancer, particularly in first-degree relatives
• Previous prostate biopsy showing atypical cells requiring surveillance

Commonly Asked Questions

Does robotic surgery mean the robot operates?

No. The surgeon controls every movement from a console. The robotic system translates the surgeon’s hand movements into instrument movements inside the patient. It filters out tremor and scales motions. There is no autonomous function. The robot cannot make decisions or perform actions without direct surgeon input.

Will I definitely need to choose between cancer control and preserving function?

Not always. For many organ-confined cancers, appropriate nerve-sparing surgery can achieve both goals. Higher-risk cancers may require wider resection for oncological safety. Your surgeon can offer personalised advice based on MRI findings, biopsy results, and PSA level. They can advise whether nerve preservation is appropriate for your specific case.

How long will it be before I can return to normal activities?

Light activities (walking, desk work) are typically possible within 1-2 weeks with robotic surgery. Open surgery typically allows these activities after 3-4 weeks. Driving resumes once you stop taking narcotic pain medication, usually 1-2 weeks. Lifting restrictions (nothing over 5 kilograms) apply for 4-6 weeks. Sexual activity can resume once comfortable, typically 4-6 weeks. Erectile recovery takes longer, though.

What if cancer is found at the surgical margins?

Positive margins increase recurrence risk. They don’t mandate immediate additional treatment, though. Many men with positive margins remain cancer-free long-term. Management options include close PSA monitoring with intervention if recurrence develops, or adjuvant radiation therapy (additional radiation treatment after surgery). The decision incorporates margin extent, Gleason grade, and patient factors. Your doctor can work with you to determine an appropriate monitoring or treatment plan tailored to your individual situation.

Can the surgery be converted from robotic to open if needed?

Yes. Conversion occurs in a small percentage of robotic cases. This typically happens due to adhesions, bleeding, or equipment issues. Urologists recognise when conversion is appropriate. They proceed safely. You should discuss this possibility during consent. It should not be a primary concern when choosing an approach, though.

Next Steps

Both approaches achieve equivalent cancer control with similar long-term functional outcomes when performed by urologists. Robotic surgery offers reduced blood loss and faster early recovery. Your choice should incorporate tumour characteristics, surgeon expertise with each technique, and personal recovery priorities.

If you’ve been diagnosed with localised prostate cancer and are experiencing elevated PSA levels, abnormal digital rectal exam findings, or urinary symptoms such as a weak stream or frequent urination, consult a urologist to evaluate which surgical approach suits your specific case.

Did you know that the prostate gland can triple in size by age 60, causing urinary symptoms in over half of men? Benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland, causes urinary symptoms that range from frequent nighttime urination to incomplete bladder emptying and a weak urine stream. When medications no longer provide adequate relief, surgical intervention becomes a consideration. Two procedures commonly used for BPH are transurethral resection of the prostate (TURP) and holmium laser enucleation of the prostate (HoLEP). Each technique removes obstructing prostate tissue through different mechanisms. Both procedures access the prostate through the urethra (the tube that carries urine out of the body), eliminating the need for external incisions. The fundamental distinction lies in how tissue is removed. TURP cuts and cauterises (seals with heat) small chips of tissue. HoLEP uses laser energy to remove entire lobes intact. This difference in technique influences recovery time, bleeding risk, and long-term durability of results.

How TURP Works

TURP has been a commonly performed procedure for BPH surgery since the 1930s. The urologist (a doctor who specialises in urinary system and male reproductive health) inserts a resectoscope (a thin viewing instrument) through the urethra. The urologist uses an electrically heated wire loop to shave away prostate tissue in small fragments. These tissue chips collect in the bladder. They are flushed out at the conclusion of the procedure.

The technique requires continuous irrigation with fluid to maintain visibility and wash away blood and tissue debris. Traditional TURP uses a non-conductive solution called glycine. Bipolar TURP uses saline (salt water), reducing certain electrolyte-related complications.

Operating time typically ranges from 1 to 1.5 hours, depending on prostate size. Spinal or general anaesthesia is required. Most patients stay in the hospital for 1 to 3 nights with a urinary catheter (a thin tube used to drain urine) in place.

How HoLEP Works

HoLEP employs a holmium laser to separate the inner portion of the prostate (adenoma) from the outer capsule. Rather than removing tissue in small chips, the surgeon shells out entire lobes of prostate tissue. This is similar to scooping the flesh from an orange while leaving the rind intact.

The detached tissue lobes drop into the bladder. A morcellator device cuts them into smaller pieces for removal and examination under a microscope. This approach removes more obstructing tissue than TURP, particularly in larger prostates.

The holmium laser simultaneously cuts tissue and seals blood vessels. This results in less bleeding during and after the procedure. Operating time ranges from around an hour for smaller prostates to over two hours for larger prostates. This reflects the thorough tissue removal rather than procedural difficulty.

Prostate Size Considerations

Prostate volume influences procedural selection. TURP works for prostates measuring in the small-to-moderate range. Above this size, operating time extends considerably. Bleeding increases, and the likelihood of incomplete tissue removal rises.

HoLEP handles prostates of various sizes. Urologists perform HoLEP on larger glands. The procedure is suitable for very large prostates. The laser’s haemostatic properties (ability to stop bleeding) maintain a clear surgical field regardless of prostate dimensions.

For smaller prostates, both procedures work well. Simpler options like transurethral incision of the prostate (TUIP, a procedure that makes minor cuts to widen the urinary channel) may be appropriate.

Blood Loss and Transfusion

TURP creates raw tissue surfaces that continue oozing blood after surgery. Patients taking blood-thinning medications face higher bleeding risks. They typically must stop these medications before TURP. Post-operative bleeding occasionally requires a return to the operating theatre or blood transfusion.

HoLEP’s laser technology coagulates (seals) blood vessels as it cuts. This reduces blood loss. Many surgeons perform HoLEP on patients who continue anticoagulation therapy (blood-thinning medication). This decision depends on individual circumstances and the specific medication involved. Transfusion requirements are lower with HoLEP.

💡 Did You Know?
The holmium laser produces light at a specific wavelength, which water absorbs almost completely. Since prostate tissue contains significant water content, the laser energy converts to heat within a fraction of a millimetre. This allows precise cutting with minimal damage to surrounding structures.

Hospital Stay and Catheter Duration

TURP patients typically require one to three nights in the hospital. The urinary catheter usually remains in place for 1 to 2 days. This extends if bleeding is significant or the urine hasn’t cleared adequately.

HoLEP often allows same-day discharge or a single overnight stay. Catheter removal is often performed within a day. Reduced bleeding and more complete tissue removal contribute to a faster initial recovery.

Both procedures may require temporary catheterisation at home if urinary retention (inability to empty the bladder) occurs during the early recovery phase.

Recovery Timeline

The first two weeks after either procedure are characterised by urinary frequency, urgency, and mild urinary burning. These irritative symptoms reflect the healing urethra and bladder adjusting to the newly opened prostate channel.

TURP recovery typically shows significant improvement within several weeks to a few months. Complete recovery occurs in a few months. Activity restrictions apply for several weeks to prevent delayed bleeding.

HoLEP recovery follows a similar pattern. Many patients return to normal activities sooner. The reduced tissue trauma from laser surgery often translates to quicker resolution of irritative symptoms.

Both procedures require avoiding heavy lifting, straining, and sexual activity during initial recovery. Blood in the urine may appear intermittently for several weeks, particularly after physical exertion. It gradually clears.

Urinary Outcomes

Both TURP and HoLEP improve urinary flow rates and reduce symptom scores. Patients experience stronger streams, more complete emptying, and reduced nighttime urination.

HoLEP removes a greater proportion of obstructing tissue. This contributes to more durable long-term results. The retreatment rate—needing another procedure because tissue has regrown—is lower with HoLEP over extended follow-up periods.

TURP provides symptom relief. Some tissue regrowth occurs over time. Some TURP patients eventually require repeat surgery. This likelihood increases as years pass.

⚠️ Important Note
Temporary urinary incontinence (loss of bladder control), particularly stress incontinence with coughing or physical activity, occurs more frequently after HoLEP during the first few months. This relates to the more complete tissue removal near the urinary sphincter (the muscle that controls urine flow). It resolves in most patients with pelvic floor exercises.

Sexual Function Effects

Both procedures carry similar risks to sexual function. Retrograde ejaculation—where semen travels backwards into the bladder rather than out through the penis—occurs in many patients after either surgery. This results from the removal of tissue that directs the typical ejaculation forward. Retrograde ejaculation is harmless but affects fertility.

Erectile function generally remains unchanged after both procedures. The surgical field lies away from the nerves controlling erection. Most men maintain their pre-operative erectile capability.

Learning Curve and Availability

TURP training is standard in urology residency programmes. Many urologists perform this procedure. Equipment is available at hospitals with urological services.

HoLEP requires additional specialised training beyond standard residency education. The technique involves complex manoeuvres. It takes considerable case volume to develop proficiency. Fewer urologists offer HoLEP. The laser equipment represents a significant capital investment not available at all facilities.

This availability difference means TURP remains more accessible in many settings. HoLEP may require referral to specific surgeons or centres with the necessary equipment and expertise.

Cost Considerations

Procedure costs vary between institutions. They depend on the duration of the hospital stay, the equipment used, and the surgeon’s fees. HoLEP’s specialised laser equipment and longer operating times for large prostates may increase facility costs. Shorter hospital stays offset some of this difference.

The higher retreatment rate after TURP represents an additional long-term cost consideration. A patient who requires a second procedure years later faces the cumulative cost of both surgeries.

Choosing Between Procedures

Several factors guide the decision between TURP and HoLEP. A healthcare professional can discuss which approach may be suitable for your specific circumstances:

• Prostate size is a consideration. For smaller to moderately sized prostates, both procedures work well. For sizes above this, HoLEP offers advantages in complete tissue removal and reduced bleeding.
• Anticoagulation status influences safety considerations. Patients requiring ongoing blood-thinning therapy may find HoLEP’s haemostatic properties advantageous.
• Recovery priorities matter for some patients. Those needing a rapid return to activities may benefit from HoLEP’s typically shorter recovery.
• Surgeon expertise influences outcomes. A surgeon, regardless of the technique, may achieve results.
• Availability limits options in many locations. If HoLEP isn’t offered locally, TURP remains an established alternative.

When to Seek Professional Help

• Urinary symptoms that don’t improve adequately with medication
• Recurrent urinary tract infections related to incomplete bladder emptying
• Bladder stones form due to urinary stasis (pooling of urine)
• Episodes of complete urinary retention requiring catheterisation
• Visible blood in urine associated with BPH
• Kidney function changes related to bladder outlet obstruction
• Significant impact on quality of life from urinary symptoms

Commonly Asked Questions

Does prostate surgery affect cancer risk or detection?

Neither procedure treats prostate cancer. Both remove tissue that undergoes examination under a microscope. This tissue analysis occasionally identifies incidental cancer. After surgery, PSA levels (a protein measured in blood to help monitor prostate health) decrease proportionally to the tissue removed. This requires adjustment of monitoring parameters.

How long do the results of prostate surgery last?

TURP results typically remain effective for an extended period. After this, some patients require additional treatment as the remaining tissue continues to enlarge. HoLEP’s more complete tissue removal results in longer-lasting outcomes. Retreatment rates remain low even at extended follow-up.

Can prostate surgery be performed if I’m taking blood thinners?

This depends on the specific medication and the procedure chosen. HoLEP is sometimes performed while continuing certain blood-thinning medications. TURP generally requires stopping anticoagulation. Your urologist and prescribing doctor will coordinate medication management based on your bleeding risk and the reason for anticoagulation.

What happens if I don’t have surgery for BPH?

Untreated severe BPH can lead to recurrent urinary tract infections, bladder stones, and bladder muscle damage from chronic straining. Rarely, it causes kidney damage due to back pressure. Medication often controls symptoms adequately. Surgery becomes appropriate when medications are insufficient or complications develop.

Will I need a catheter after prostate surgery?

Yes, a urinary catheter is placed during surgery. It remains temporarily afterwards. Duration ranges from several hours to several days, depending on the procedure, prostate size, and individual healing. Some patients leave the hospital with a catheter to be removed at a follow-up appointment.

Next Steps

Prostate size, anticoagulation requirements, and surgeon expertise determine which procedure is ideal for your situation. HoLEP offers lower retreatment rates and reduced bleeding risk, while TURP remains widely available with established long-term outcomes.

If you’re experiencing a weak urinary stream, frequent nighttime urination, or incomplete bladder emptying that medications haven’t adequately controlled, a urologist can evaluate your prostate size, discuss whether TURP or HoLEP is appropriate, and recommend the most suitable option for your circumstances.